PE
OLMA icon

Point72 Europe’s Olema Pharmaceuticals OLMA Stock Holding History

Point72 Europe’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.96K Buy
+404
New +$2.43K ﹤0.01% 616

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Point72 Europe's OLMA Position: Q3 2025 in Review

Point72 Europe opened a new position in Olema Pharmaceuticals (OLMA) in Q3 2025: 404 shares worth $3.96K. The stake represents ﹤0.01% of the portfolio and ranks #616 among its holdings.

126 funds tracked by Wall St. Rank hold OLMA as of Q3 2025.

  • Point72 Europe held 404 shares of Olema Pharmaceuticals worth $3.96K as of Q3 2025.
  • Olema Pharmaceuticals was a new Point72 Europe position in Q3 2025.
  • Olema Pharmaceuticals made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #616 holding.
  • 126 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.